CENTRAL SURGERY — All Prescriptions & Medications — Page 4
Practice Code: H84030 | SURBITON, KT6 6EZ
Showing results 151-200 of 641
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Methylphenidate hydrochloride | 359 | 13.2K | £11.4K | +39.0% ▲ |
| Letrozole | 356 | 16.2K | £1.4K | +90.6% ▲ |
| Loperamide hydrochloride | 352 | 41.1K | £1.4K | +51.1% ▲ |
| Loratadine | 339 | 18.5K | £441 | +62.2% ▲ |
| Brinzolamide | 331 | 2,785 | £2.0K | +154.8% ▲ |
| Prochlorperazine maleate | 327 | 11.8K | £772 | +61.8% ▲ |
| Insulin glargine | 327 | 1,799 | £17.6K | +15.2% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 308 | 16.5K | £1.2K | +101.7% ▲ |
| Trimethoprim | 306 | 12.0K | £601 | +49.8% ▲ |
| 302 | 34.1K | £2.2K | +340.9% ▲ | |
| Aciclovir | 301 | 17.1K | £957 | +102.4% ▲ |
| Estriol | 300 | 3,204 | £6.4K | +41.0% ▲ |
| Oxybutynin | 300 | 15.7K | £3.3K | +57.5% ▲ |
| Lymecycline | 293 | 16.3K | £1.9K | +143.6% ▲ |
| Fluticasone propionate (Inhalation) | 289 | 380 | £9.4K | -25.3% ▼ |
| Ranolazine | 288 | 10.0K | £1.8K | +69.5% ▲ |
| Mebeverine hydrochloride | 287 | 15.8K | £915 | -7.6% ▼ |
| Lercanidipine hydrochloride | 287 | 8,379 | £856 | -53.5% ▼ |
| Tadalafil | 285 | 3,750 | £728 | +67.6% ▲ |
| Dorzolamide and timolol | 283 | 7,140 | £5.1K | +97.7% ▲ |
| Sacubitril/valsartan | 278 | 11.8K | £19.3K | +16.1% ▲ |
| Betahistine hydrochloride | 277 | 22.1K | £756 | +16.0% ▲ |
| Clonazepam | 277 | 9,557 | £1.4K | +77.8% ▲ |
| Bimatoprost | 275 | 3,825 | £2.5K | +85.0% ▲ |
| Paroxetine hydrochloride | 273 | 9,674 | £366 | +46.3% ▲ |
| Topiramate | 269 | 9,157 | £2.9K | +51.4% ▲ |
| Alfuzosin hydrochloride | 269 | 9,330 | £3.4K | +276.0% ▲ |
| Fusidic acid | 268 | 5,745 | £712 | +109.9% ▲ |
| Carmellose sodium | 265 | 15.4K | £2.2K | +309.0% ▲ |
| Dexamethasone | 258 | 1,360 | £848 | +50.0% ▲ |
| Calcipotriol | 258 | 19.7K | £11.2K | +51.6% ▲ |
| Timolol | 256 | 6,615 | £2.0K | +189.4% ▲ |
| Azithromycin | 254 | 4,703 | £1.7K | +100.4% ▲ |
| Oxycodone hydrochloride | 252 | 34.2K | £4.5K | -1.5% vs avg |
| Biphasic insulin aspart | 251 | 1,670 | £9.9K | +147.2% ▲ |
| Ivabradine | 250 | 7,924 | £1.3K | +163.0% ▲ |
| Typhoid | 249 | 249 | £2.6K | +176.5% ▲ |
| Insulin detemir | 246 | 1,627 | £13.7K | +214.1% ▲ |
| Dorzolamide | 236 | 5,490 | £3.1K | +184.0% ▲ |
| Pancreatin | 235 | 46.1K | £12.1K | +111.4% ▲ |
| Cefalexin | 230 | 8,651 | £513 | +97.7% ▲ |
| Alfacalcidol | 229 | 10.1K | £1.7K | +85.2% ▲ |
| Mesalazine (Systemic) | 228 | 30.8K | £13.9K | -4.8% ▼ |
| Clobetasol propionate | 225 | 20.5K | £1.7K | +64.9% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 219 | 253 | £11.1K | +30.9% ▲ |
| Hydrocortisone | 219 | 12.1K | £3.0K | +159.4% ▲ |
| Lacosamide | 218 | 9,030 | £3.6K | +305.6% ▲ |
| Carbomer 940/980 | 215 | 3,400 | £850 | +41.2% ▲ |
| Hydroxychloroquine sulfate | 210 | 12.3K | £688 | +8.4% ▲ |
| Clobazam | 209 | 4,523 | £587 | +217.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.